中国癌症研究(英文版)2024,Vol.36Issue(3) :322-340.DOI:10.21147/j.issn.1000-9604.2024.03.08

Unlocking epigenetics for precision treatment of Ewing's sarcoma

Zhehao Fan Shuangshuang Dong Ning Wang Muhammad Babar Khawar Jingcheng Wang Haibo Sun
中国癌症研究(英文版)2024,Vol.36Issue(3) :322-340.DOI:10.21147/j.issn.1000-9604.2024.03.08

Unlocking epigenetics for precision treatment of Ewing's sarcoma

Zhehao Fan 1Shuangshuang Dong 2Ning Wang 1Muhammad Babar Khawar 1Jingcheng Wang 3Haibo Sun1
扫码查看

作者信息

  • 1. Institute of Translational Medicine,Medical College,Yangzhou University,Yangzhou 225001,China;Jiangsu Key Laboratory of Experimental &Translational Non-Coding RNA Research,Yangzhou 225001,China
  • 2. Department of Pathology,Northern Jiangsu People's Hospital Affiliated to Yangzhou University/Clinical Medical College,Yangzhou University,Yangzhou 225001,China
  • 3. Department of Orthopedics,Northern Jiangsu People's Hospital Affiliated to Yangzhou University,Yangzhou 225001,China
  • 折叠

Abstract

Ewing's sarcoma(EWS)is a highly aggressive malignant bone tumor primarily affecting adolescents and young adults.Despite the efficacy of chemoradiotherapy in some cases,the cure rate for patients with metastatic and recurrent disease remains low.Therefore,there is an urgent need for innovative therapeutic approaches to address the challenges associated with EWS treatment.Epigenetic regulation,a crucial factor in physiological processes,plays a significant role in controlling cell proliferation,maintaining gene integrity,and regulating transcription.Recent studies highlight the importance of abnormal epigenetic regulation in the initiation and progression of EWS.A comprehensive understanding of the intricate interactions between EWS and aberrant epigenetic regulation is essential for advancing clinical drug development.This review aims to provide a comprehensive overview of both epigenetic targets implicated in EWS,integrating various therapeutic modalities to offer innovative perspectives for the clinical diagnosis and treatment of EWS.

Key words

Ewing's sarcoma/epigenetic/targets/drug resistance/drug development

引用本文复制引用

基金项目

National Natural Science Foundation of China(82371877)

Advanced Talents and Science and Technology Innovation Foundation at Yangzhou University(137011856)

Advanced Talents and Science and Technology Innovation Foundation at Yangzhou University(HS)

出版年

2024
中国癌症研究(英文版)
中国抗癌协会 北京市肿瘤研究所

中国癌症研究(英文版)

CSTPCDCSCD
影响因子:1.592
ISSN:1000-9604
参考文献量117
段落导航相关论文